drugset / Trial / NCT00901290

Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects

NCT00901290

Phase 1 Suspended 56 enrolled AstraZeneca
RandomizedCrossoverDouble-blind

Summary

The purpose of this study is to evaluate the effect of repeated doses of AZD7325 on the pharmacokinetics of ORTHO-CYCLEN, a monophasic oral contraceptive

Timeline

Start
2009-05
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7325 Small molecule Oral
Subject Ortho-Cyclen Unknown Oral

Indications

No indication recorded.